Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lehto Group Plc: Shareholders’ Nomination Committee’s proposals to the Annual General Meeting 2022

Lehto Group PlcStock exchange release1 February 2022 at 3.30 p.m (EET)Lehto Group Plc Annual General Meeting is planned to be held on 31 March 2022. The Shareholder Nomination Committee’s gives the following proposals to the Annual General Meeting regarding the number, the composition, and the remuneration of the Members of the Board of Directors. The number of the Members of the Board of Directors The Shareholders’ Nomination Committee proposes that the number of Board members is five (5). The composition of the Members of the Board of Directors The Shareholders’ Nomination

Invitation to RevolutionRace’s presentation of the interim report for the second quarter and first half-year 2021/22

RVRC Holding AB (publ) will publish its interim report for the second quarter and first half-year 2021/22 on February 8, 2022 at 07:15 CET. The report will be presented in a webcast and teleconference at 10:00 the same day.Pernilla Nyrensten, CEO and Jesper Alm, CFO will present the report and answer questions. The presentation will be held in English. Follow the presentation live on: https://financialhearings.com/event/41506 To listen to the conference by phone, please dial: SE: +46856642704 UK: +443333009261 US: +16467224903 For more information, please contact:

Karolinska University Hospital First to Give Stem Cells to Foetus with Severe Osteoporosis

A new treatment is being trialled to help children born with a severe variant of osteoporosis, osteogenesis imperfecta. It is the first clinical trial in the world in which bone-forming stem cells are given before birth. The hope is that this will increase the child's chances of building a functioning skeleton.Osteogenesis imperfecta is a congenital genetic disorder in which the collagen type 1 protein is defective, or not produced in sufficient amounts, preventing the bones from storing enough calcium, and growing strong. The skeleton is also remodelled too quickly, which contributes to

N-KOM and ABS JDP to Explore Using Remote Survey Techniques to Augment Shipyard Surveys

Remote Technologies to be Trialled on Surveys After Construction in the Shipyard (DOHA)  A pioneering joint development project (JDP) between ABS and Nakilat - Keppel Offshore & Marine Ltd. (N-KOM) will examine how techniques developed by ABS for its industry leading program of remote survey of vessels in service can be applied to surveys and inspections in the shipyard. Remote inspection technologies will be applied to six Class surveys for this trial, to test how they can then be used to verify the required survey or inspection by ABS Surveyors to optimize scheduling and

Akelius presents the result for 2021

On Monday, 2022-02-07, Akelius publishes its year-end report for 2021. Akelius invites investors to participate in a teleconference at 10:00 am Central European Time. Ralf Spann, CEO, and Leiv Synnes, CFO, will present the report and answer questions. The presentation is held in English. If you want to participate, please register via the following linkhttps://www.incommglobalevents.com/registration/client/9877/akelius-q4-results/You will then receive the telephone number and pin code.  Berlin, 2022-02-01 Ralf SpannCEO+49 173 643 65 90ralf.spann@akelius.de (

New Type of Medical Helicopter Provides Intensive Care in Transit

Karolinska University Hospital will be the first in Sweden to have a new type of medical helicopter that can provide the sickest patients with advanced care, even in the air. The helicopter can bring patients from all over the country to Karolinska.A contract for the operation and delivery of an Agusta Westland 139 (AW 139) helicopter has been signed by the supplier, Babcock, and Karolinska. Karolinska will get access to a temporary helicopter in March, 2022, and at the beginning of 2023, the permanent helicopter will be delivered. - Karolinska will be the first hospital in Sweden to

Tokmanni’s big surprise – New lifestyle brand based on the shop-in-shop principle coming soon

Tokmanni     Press release     1 February 2022 at 2:00 p.m. Tokmanni’s latest surprise, the new lifestyle brand Miny, will arrive in selected Tokmanni stores and Tokmanni's online store around the turn of February and March. Tokmanni, Finland’s largest variety discount retailer, has a new surprise: it is launching a lifestyle brand called Miny with around 1,000 different products. The products will be available around the turn of February and March when Miny’s first shop-in-shop departments will open in selected Tokmanni stores in Helsinki, Vantaa and Hyvinkää. The new Miny

Scandinavian ChemoTech attains ISO 13485 certificate

During 2021 ChemoTech has, after securing its CE-mark for its IQwave system, continued to develop its quality management system to ensure that it follows both existing and upcoming requirements for medical devices.Scandinavian ChemoTech has attained certificate for ISO 13485 issued by RISE, Research Institute of Sweden AB. The company’s quality management system for medical devices fulfils the requirements of SS-EN ISO 13485:2016 with respect to “Design and development, production, marketing, sales, distribution and services of products within electroporation”. “This is a profound

Fazer Group signs an EUR 200 million revolving credit facility linked to sustainability targets

Fazer has signed a new EUR 200 million revolving credit facility (RCF) agreement linked to sustainability targets to be used for general corporate purposes. Under the RCF, Fazer is committed to meeting the following two sustainability targets: the reduction of Greenhouse Gas emissions (CO\2\e) and avoidable production food loss. The margin payable will increase or decrease depending on Fazer’s performance and achievement of these sustainability KPIs. “This RCF is a milestone in the integration of our financial and sustainability targets as it reinforces the interlinkage between our

KlaraBo got land allocated in Skelleftea for about 130 sustainable apartments

KlaraBo has received a land allocation at Anderstorg in Skelleftea. The area has a completed zoning plan that allows construction of approximately 10,000 sqm of BTA, or the equivalent of approximately 130 rental apartments. The homes will maintain a high sustainability standard and building design will begin immediately. Anderstorg is centrally located with proximity to, among other things, university campuses, preschools, and schools as well as retail stores. The intention is to develop environmentally friendly, sustainable housing built mainly in wood in collaboration with the

Wärtsilä Corporation - Manager's transaction: Agnevall, Håkan

Wärtsilä Corporation, Managers' transactions, 1 February 2022 at 13.30 EETWärtsilä Corporation - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Agnevall, HåkanPosition: Chief Executive OfficerIssuer: Wärtsilä CorporationLEI: 743700G7A9J1PHM3X223 Notification type: INITIAL NOTIFICATIONReference number: 743700G7A9J1PHM3X223_20220201081254_6____________________________________________ Transaction date: 2022-01-31Venue: XHELInstrument type: SHAREISIN: FI0009003727Nature of the transaction:

NPRO: Approval of base prospectus, listing of bonds and change of ISIN

The Financial Supervisory Authority of Norway has on 26th January 2022 approved Norwegian Property ASA’s base prospectus, and it is available at Norwegian Property ASA’s website www.norwegianproperty.no/wp-content/uploads/2022/01/Base-Prospectus-med-mal-Norwegian-Property-ASA-datert-26.01.2022.pdf . The prospectus has been prepared in connection with the listing on the Oslo Stock Exchange of the following bond issues on 2[nd] February 2022: · FRN Norwegian Property ASA Secured Bond Issue 2021/2026 with ISIN NO 0011086969 and issued amount NOK 200 000 000, issued on 9[th] September

XMReality signs global framework agreement with Verisure

Verisure SARL, the Swiss headquarter of Verisure, and XMReality AB have signed a global framework agreement for XMReality Remote Guidance. Verisure will initially make a deployment of XMReality Remote Guidance in their technical support function for home alarms in Sweden.Verisure is a leading provider of professionally monitored security solutions. The company has more than 4 million customers in 16 countries across Europe and Latin America. Their business model integrates product development, design and sales with installation, service and a 24/7 professional monitoring solution. “We

Recipharm acquires GenIbet to bolster Biologics offering

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the Biologics market, with a particular focus on drug substance manufacturing of novel ATMPs. GenIbet currently works with customer projects in the preclinical and Phase 1 stages and has a track record of developing novel production processes.

SAGAX INVESTS SEK 452 MILLION THROUGH 7 TRANSACTIONS

Sagax has through seven separate transactions acquired 9 properties for the equivalent of SEK 452 million. The properties comprise a lettable area of 42,900 square metres, mainly consisting of premises for warehousing and light industrial purposes. The annual rental income amounts to the equivalent of SEK 34 million. The occupancy rate is 98% and the average remaining lease term is 4.5 years. Closing will take place during the first quarter of 2022. The acquisitions will be reported in Sagax’s segments Netherlands (SEK 211 million), Helsinki (SEK 176 million), Madrid & Barcelona (SEK 13

The Nomination Committee’s proposal regarding election of Board of Directors in Lindab

The Nomination Committee in Lindab International AB (publ) consists of, Per Colleen (chair), appointed by Fjärde AP-fonden, Anna Sundberg appointed by Handelsbanken Fonder, Per Trygg, appointed by Lannebo Fonder and Peter Nilsson, chairman of the Board of Lindab International AB (publ). The Nomination Committee proposes re-election of the Board members Per Bertland, Sonat Burman-Olsson, Viveka Ekberg, Anette Frumerie, Marcus Hedblom, Peter Nilsson and Staffan Pehrson. The Nomination Committee proposes re-election of Peter Nilsson as chairman of the Board. The Nomination Committee's

Invitation to presentation of Sinch Year-End Report 2021

Stockholm, Sweden – February 1, 2022 – Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, will publish its Year-End Report for 2021 on Thursday, February 17, 2022, at 07:30 CET. A conference call and a webcast will take place at 14:00 CET the same day where Oscar Werner, CEO, and Roshan Saldanha, CFO, will present the report. There will be a possibility to ask questions after the presentation. Time for publication of the interim reportThursday February 17, 2022, at 07:30 CET Time for conference call and webcastThursday February 17, 2022, at 14:

Resolutions from the extraordinary general meeting in Cint Group AB (publ)

At the extraordinary general meeting in Cint Group AB (publ) (the “Company”) held on 1 February 2022 it was resolved to elect two new members of the board of directors, to elect a new chair of the board of directors and to determine the remuneration to the new members of the board of directors.Election of new members of the board of directors The general meeting resolved, in accordance with the nomination committees’ proposal, to elect Patrick Comer and Carl Sparks as new members of the board of directors in the Company for the period until the end of the next annual general meeting. The

Invitation for presentation of Pricer’s interim report for the fourth quarter 2021

Pricer AB will present its interim report for the fourth quarter 2021 in an audiocast on February 11 at 13.00 CET.According to the financial calendar, Pricer will publish the report for the fourth quarter 2021 on Friday February 11 at approximately 8.30 CET. Pricer hereby invites to a presentation of the report on the same day. Pricer’s CEO Helena Holmgren will present the report and answer questions. Date: February 11, 2022 Time: 13.00 CET Link to the audiocast: https://financialhearings.com/event/41677 For further information, please contact: Helena Holmgren, President and

SelectImmune Pharma files important patent application for acute pyelonephritis

SelectImmune Pharma AB has filed for patent protection over a range of new agents that show surprising levels of activity in treatment of pyelonephritis. This new patent application adds to SelectImmune Pharma’s expanding range of intellectual property rights in the pharmaceutical sector, specifically for treating bacterial infections.Acute pyelonephritis or kidney infection, is a severe and common form of urinary tract infection, caused by bacteria that directly infect the kidneys. In about 30% of adults with acute pyelonephritis, bacteria invade the blood stream, causing urosepsis and

Pohjola Hospital is now part of Pihlajalinna

Pihlajalinna Plc                  Stock Exchange Release               1 February 2022 at 11.20 a.m. Pohjola Hospital is now part of Pihlajalinna Pihlajalinna’s acquisition of Pohjola Hospital is completed today, 1 February 2022. The Finnish Competition and Consumer Authority (KKV) approved the acquisition on 14 January without conditions. In the acquisition, the entire share capital of Pohjola Hospital Oy will be transferred to Pihlajalinna Terveys Oy. The acquisition is a key part of Pihlajalinna’s growth strategy and will strengthen the service portfolio in all areas of

Analysguiden has completed an analysis of Stayble Therapeutics and initiates equity research coverage

Analysguiden has completed an analysis of Stayble Therapeutics. The analysis is available at the following link: https://www.aktiespararna.se/analysguiden/nyheter/initieringsanalys-stayble-therapeutics-unik-behandling-diskrelaterad-ryggsmarta“We are focusing on continuing the development of STA363 to offer an effective and alternative treatment for chronic back pain. While we continue to work on our phase 2b study, we also want to take the opportunity to increase the knowledge and understanding of our ambitions regarding the treatment of back pain and talk more about our drug candidate. As

Innovative companies need Innovative suppliers

Nidec Control Techniques has been a supplier for AccuTech Weighing Services for over a decade. Their successful working relationship demonstrates the importance of shared goals when fostering industrial innovation.Africa is known for its abundance of natural resources. It is also home to a growing, urbanising and modernising population. Meeting the needs of businesses and consumers in this dynamic landscape requires local companies to embrace technology to gain the competitive edge, enabling process efficiencies and improved productivity. Exemplifying this, AccuTech Weighing Services is

There are no items matching the current filter
There are no more items matching the current filter
Back to top